Crenezumab (MABT 5102A, RG 7412) is a fully humanized anti-Abeta monoclonal antibody that binds multiple forms of Abeta, such as soluble, oligomeric and fibrillar, for use in Alzheimers disease research.
CAS Number:
[1095207-05-8]
Target:
Amyloid
* VAT and and shipping costs not included. Errors and price changes excepted
